NSG 552 Psychopharm Exam 2 2026 – 120+ Practice Questions on Anxiety Disorders, PTSD, OCD, Insomnia & Sleep Pharmacology | NSG 552 Advanced Psychopharmacology

This comprehensive NSG 552 Psychopharm Exam 2 study guide contains over 120 high-yield practice questions and answers covering evidence-based pharmacologic management of anxiety disorders, trauma-related conditions, obsessive-compulsive spectrum disorders, insomnia, sleep-wake disorders, eating disorders, and psychopharmacologic safety considerations. Designed for Psychiatric Mental Health Nurse Practitioner (PMHNP) students and advanced practice providers, this resource transforms complex psychiatric prescribing concepts into an active recall format that strengthens clinical reasoning, enhances medication safety awareness, and improves performance on graduate psychopharmacology examinations and PMHNP certification assessments. The material integrates treatment algorithms, medication mechanisms of action, therapeutic monitoring, patient counseling strategies, and guideline-based recommendations frequently emphasized in advanced psychiatric nursing curricula. The anxiety disorders section provides an in-depth review of first-line pharmacologic interventions for Generalized Anxiety Disorder (GAD), panic disorder, and social anxiety disorder. Students will strengthen their understanding of the role of Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) as preferred long-term treatment options, while differentiating the clinical use of tricyclic antidepressants, beta-blockers, buspirone, and benzodiazepines. Learners will explore the impact of underlying medical conditions that may precipitate anxiety symptoms, including thyroid disease, diabetes mellitus, seizure disorders, chronic obstructive pulmonary disease, asthma, and cardiovascular conditions. Extensive coverage of benzodiazepine pharmacology examines mechanisms of action at the GABA-A receptor complex, indications for short-term use, and evidence-based approaches to risk mitigation. Students will review medication selection in special populations, including the use of lorazepam, oxazepam, and temazepam in individuals with hepatic impairment or alcohol-related liver disease. The guide emphasizes the recognition of tolerance, dependence, rebound insomnia, withdrawal syndromes, seizure risk associated with abrupt discontinuation, and the implementation of gradual tapering strategies supported by cognitive behavioral interventions. Emergency management principles involving flumazenil reversal and overdose recognition are also explored in detail. The insomnia and sleep medicine component delivers comprehensive review of sleep-onset and sleep-maintenance pharmacotherapy. Students will differentiate among non-benzodiazepine hypnotics, melatonin receptor agonists, benzodiazepines, orexin receptor antagonists, sedating antidepressants, and their respective roles in managing chronic insomnia. Particular emphasis is placed on medication selection in geriatric populations, the use of ramelteon as a non-habit-forming alternative, the risks associated with long-acting benzodiazepines in older adults, and the foundational importance of sleep hygiene as first-line therapy. The guide further explores narcolepsy, restless legs syndrome (RLS), and obstructive sleep apnea management. Learners will review the pathophysiology of hypocretin deficiency, indications for modafinil and sodium oxybate, patient counseling regarding central nervous system depressants, and evidence-based non-pharmacologic interventions such as scheduled naps, weight reduction, continuous positive airway pressure (CPAP), and lifestyle modification. Pharmacologic options for RLS, including dopamine agonists and gabapentinoids, are integrated into clinically relevant scenarios that support advanced prescribing competence. Obsessive-Compulsive Disorder (OCD), Post-Traumatic Stress Disorder (PTSD), and Dissociative Identity Disorder (DID) are examined extensively through contemporary treatment frameworks. Students will strengthen their understanding of combining pharmacotherapy with psychotherapy, identify FDA-approved medications for OCD and PTSD, and evaluate augmentation strategies involving atypical antipsychotics in treatment-resistant presentations. Topics include the use of prazosin for trauma-related nightmares, the rationale for avoiding benzodiazepines in PTSD populations, and the role of SSRIs in addressing comorbid depressive and anxiety symptoms across dissociative disorders. Comprehensive review of eating disorder pharmacology prepares learners to manage anorexia nervosa, bulimia nervosa, and binge eating disorder using evidence-based interventions. Students will examine indications for fluoxetine, escitalopram, lisdexamfetamine, olanzapine, alprazolam, and adjunctive agents such as orlistat, while recognizing contraindications including the avoidance of bupropion in patients with eating disorders due to increased seizure risk. The integration of psychotherapeutic modalities and family-based interventions further supports holistic psychiatric care. Special emphasis is placed on antidepressant safety considerations, including serotonin syndrome, SSRI discontinuation syndrome, and medication-related adverse effects frequently encountered in psychiatric practice. Learners will develop confidence in identifying early warning signs, implementing appropriate interventions, and providing comprehensive patient education to optimize adherence and therapeutic outcomes. This study guide is particularly valuable for Psychiatric Mental Health Nurse Practitioner (PMHNP) students, Master of Science in Nursing (MSN) students, Doctor of Nursing Practice (DNP) students, psychiatric nursing students, advanced practice registered nurses, physician assistant students specializing in behavioral health, psychiatry residents, nurse practitioner certification candidates, and healthcare professionals seeking a focused review of evidence-based psychopharmacology principles. The content aligns with established evidence-based standards and authoritative references, including: Stahl, S. M. (2024). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (6th ed.). Cambridge University Press. Stahl, S. M. (2024). Stahl's Essential Psychopharmacology Prescriber's Guide (8th ed.). Cambridge University Press. American Psychiatric Association. (2023). Practice Guideline for the Treatment of Anxiety Disorders, Obsessive-Compulsive Disorder, and Trauma-Related Conditions. Townsend, M. C., & Morgan, K. I. (2024). Psychiatric Mental Health Nursing: Concepts of Care in Evidence-Based Practice (11th ed.). F.A. Davis. Sadock, B. J., Sadock, V. A., & Ruiz, P. (2022). Kaplan & Sadock's Synopsis of Psychiatry (12th ed.). Wolters Kluwer. National Institute for Health and Care Excellence (NICE). Current recommendations regarding insomnia management, anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder. American Academy of Sleep Medicine (AASM). Evidence-based guidance for insomnia, narcolepsy, restless legs syndrome, and sleep disorder management. Designed as both an intensive examination review and a practical psychopharmacology companion, this study guide promotes active learning, strengthens prescribing confidence, enhances medication safety awareness, and prepares learners to integrate evidence-based psychiatric treatment strategies into advanced clinical practice. Keywords: NSG 552, Psychopharm Exam 2, Advanced psychopharmacology, Anxiety disorders, Generalized anxiety disorder, GAD, Panic disorder, Social anxiety disorder, Performance anxiety, SSRIs, SNRIs, Buspirone, Benzodiazepines, GABA-A receptors, Lorazepam, Oxazepam, Temazepam, Flumazenil, Benzodiazepine withdrawal, Benzodiazepine tapering, Insomnia treatment, Sleep hygiene, Ramelteon, Zolpidem, Eszopiclone, Zaleplon, Suvorexant, Doxepin, Trazodone, Mirtazapine, Narcolepsy, Modafinil, Sodium oxybate, Restless legs syndrome, RLS, Pramipexole, Ropinirole, Obstructive sleep apnea, CPAP, OCD treatment, Obsessive-compulsive disorder, Fluvoxamine, Clomipramine, PTSD treatment, Prazosin, Trauma-related nightmares, Dissociative identity disorder, DID, Eating disorders, Anorexia nervosa, Bulimia nervosa, Binge eating disorder, Fluoxetine, Escitalopram, Lisdexamfetamine, Olanzapine, Orlistat, Bupropion contraindications, Serotonin syndrome, SSRI discontinuation syndrome, PMHNP exam preparation, Psychiatric nursing review, Nurse practitioner certification review